Comprehensive Dermatologic Drug Therapy (4th Edition)

Description

Designed with practical usability in mind, Comprehensive Dermatologic Drug Therapy, 4th Edition, helps you safely and effectively treat the skin disorders you’re likely to see in your practice. Dr. Stephen E. Wolverton and new associate editor Dr. Jashin J. Wu lead a team of global experts to bring you concise, complete guidance on today’s full spectrum of topical, intralesional, and systemic drugs. You’ll prescribe with confidence thanks to expert coverage of which drugs to use, when to use them, and adverse effects to monitor.

Table of Contents

1. Part I: Introduction
   1. Basic Principles of Pharmacology
   2. Principles for Maximizing the Safety of Dermatologic Drug Therapy
   3. Polymorphisms: Why Individual Drug Responses Vary
   4. Adherence to Drug Therapy
   5. Medical Decision Making
2. Part II: Important Drug Regulatory Issues
   1. The FDA Drug Approval Process
   2. Pharmacovigilance: Verifying that Drugs Remain Safe
   3. Drugs Taken Off the Market: Important Lessons Learned
3. Part III: Systemic Drugs for Infectious Diseases
   1. Systemic Antibacterial Agents
   2. Systemic Antifungal Agents
   3. Systemic Antiviral Agents
   4. Systemic Antiparasitic Agents
4. Part IV: Systemic Immunomodulatory Drugs
   1. Systemic Corticosteroids
   2. Methotrexate
   3. Azathioprine
   4. Mycophenolates
   5. Cyclosporine
   6. Phosphodiesterase-4 and Janus Kinase Inhibitors
   7. Cytotoxic Agents
   8. Dapsone
   9. Antimalarial Agents
   10. Systemic Retinoids
5. Part V: Drugs Used in Conjunction with UV or Visible Light
   1. Psoralen Plus Ultraviolet A Photochemotherapy and Other Phototherapy Modalities
   2. Extracorporeal Photochemotherapy (Photopheresis)
   3. Photodynamic Therapy
6. Part VI: Biologic Therapeutics
   1. Tumor Necrosis Factor Inhibitors
   2. Interleukin 12/23 Inhibitors
   3. Interleukin 17 Inhibitors
   4. Interleukin 23 Inhibitors
   5. Rituximab
   6. Additional Biologic Therapeutics: Dupilumab, Omalizumab, Others
7. Part VII: Miscellaneous Systemic Drugs
   1. Antihistamines
   2. Vasoactive and Antiplatelet Agents
   3. Antiandrogens and Androgen Inhibitors
   4. Psychotropic Agents
   5. Intravenous Immunoglobulin Therapy
   6. Systemic Anticancer Agents: Dermatologic Indications and Adverse Events
   7. Hedgehog Pathway Inhibitors
   8. Drugs for the Skinternist
   9. Miscellaneous Systemic Drugs
8. Part VIII: Topical Drugs for Infectious Diseases
   1. Topical Antibacterial Agents
   2. Topical Antifungal Agents
   3. Topical and Intralesional Antiviral Agents
   4. Topical Antiparasitic Agents
9. Part IX: Topical Immunomodulatory Drugs
   1. Topical Corticosteroids
   2. Topical Retinoids
   3. Topical and Intralesional Chemotherapeutic Agents
   4. Topical Calcineurin Inhibitors
   5. Topical Vitamin D3
10. Part X: Miscellaneous Topical Drugs
    1. Sunscreens
    2. Therapeutic Shampoos
    3. α-Hydroxy Acids
    4. Chemical Peels
    5. Products for the Care of Chronic Wounds
    6. Agents Used for Treatment of Hyperkeratosis
    7. Irritants and Allergens: When to Suspect Topical Therapeutic Agents
    8. Miscellaneous Topical Agents
    9. Part XI: Injectable and Mucosal Routes of Drug Administration
    10. Local Anesthetics
    11. Injectable Dermal and Subcutaneous Fillers
    12. Botulinum Toxin Injections
    13. Oral Mucosal Therapeutics
11. Part XII: Major Adverse Effects From Systemic Drugs
    1. Hepatotoxicity of Dermatologic Drug Therapy
    2. Hematologic Toxicity of Drug Therapy
    3. Drug-induced Malignancy
    4. Dermatologic Drugs During Pregnancy and Lactation
    5. Drug Interactions
    6. Cutaneous Drug Reactions With Systemic Features
12. Part XIII: Special Pharmacology and Therapeutics Topics
    1. Informed Consent and Risk Management
    2. Compounding in Dermatology
    3. Dermatologic Drug Therapy in Children
    4. Appendix I Core Questions for Understanding Systemic Dermatologic Drugs
    5. Appendix II The Most Potentially Serious Drug Interactions

Author Biography

Stephen Wolverton

Affiliations and Expertise
Professor of Clinical Dermatology Vice Chair of Clinical Affairs

Jashin Wu

Affiliations and Expertise
Founder and Course Director, San Diego Dermatology Symposium; Founder and CEO Dermatology Research and Education Foundation Irvine, California, USA